We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Foamix Pharmaceuticals Ltd | NASDAQ:FOMX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.99 | 2.80 | 4.00 | 0 | 01:00:00 |
(1)
|
To approve the terms of cash compensation of Mr. David Domzalski, our Chief Executive Officer, for the period commencing as of July 1, 2017, and onward.
|
(2)
|
To approve the award of options and restricted share units to Mr. David Domzalski.
|
FOAMIX PHARMACEUTICALS LTD.
(Registrant)
|
|||
By:
|
/s/ Ilan Hadar
|
||
Name: Ilan Hadar
|
|||
Title: Country Manager & CFO
|
|||
1 Year Foamix Pharmaceuticals Chart |
1 Month Foamix Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions